Corinne Isnard Bagnis
Paris, 75013, France
NCT Number: NCT02457494
The purpose of this study is to define the cause of renal stones and the risk pattern for recurrence of renal stones episodes (any kind of stones) in HIV1 patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Paris, 75013, France
This study aims at defining the cause of renal stones and the risk pattern for recurrence of renal stones episodes (any kind of stones) in HIV1 patients.
Primary Objective :
Secondary Objective(s)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at 6 months
Qualitative assessment of the cause of the renal stone based on different biological and clinical parameters (biochemical analysis of urines, cristalluria, low dose renal CT, patient history, family history…)
Time frame: at 12 months
Risk profile for recurrence of renal stone estimated based on plasma and urinary parameters, nutritional profile and drug exposure
Time frame: up to 12 months
Time frame: up to 12 months
Time frame: up to 12 months
Time frame: at 6 months
Time frame: at 12 months
Corinne Isnard Bagnis
Other
CALVIH: Determination of Kidney Stone Risk Factors in Patients Infected With HIV
Acronym: CALVIH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02878148
Acute Renal Colic, Disease
Montpellier, France
View Trial DetailsNCT07126847
Calculi, Female Urogenital Diseases
Kocaeli, İzmit, Turkey (Türkiye)
View Trial DetailsNCT05014178
ADPKD, Abnormalities, Multiple
London, Ontario, Canada
View Trial DetailsNCT07457983
Calculi, Female Urogenital Diseases
Adıyaman, Turkey (Türkiye)
View Trial Details